MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$398K
Net Income
-$28,919K
Net Profit Margin
-7266.08%
EPS
-$18.62
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2025-12-31
Collaboration revenue
398
Research and development
18,411
General and administrative
11,540
Restructuring and other related charges
1,469
Total operating expenses
31,420
Loss from operations
-31,022
Interest income
1,133
Other income
981
Total other income
2,114
Loss before income tax expense
-28,908
Income tax expense
11
Net loss
-28,919
Comprehensive loss
-28,919
Basic EPS
-18.62
Diluted EPS
-18.62
Basic Average Shares
1,553,473
Diluted Average Shares
1,553,473
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$28,919K
Net loss
-$28,919K
Interest income
$1,133K
Other income
$981K
Loss before income
tax expense
-$28,908K
Income tax expense
$11K
Total other income
$2,114K
Loss from operations
-$31,022K
Collaboration revenue
$398K
Total operating
expenses
$31,420K
Research and development
$18,411K
General and
administrative
$11,540K
Restructuring and other
related charges
$1,469K
Buy us a coffee
Lyra Therapeutics, Inc. (LYRA)
Lyra Therapeutics, Inc. (LYRA)